These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21968316)

  • 1. A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis.
    Protogerou AD; Zampeli E; Fragiadaki K; Stamatelopoulos K; Papamichael C; Sfikakis PP
    Atherosclerosis; 2011 Dec; 219(2):734-6. PubMed ID: 21968316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis.
    Fragiadaki K; Tektonidou MG; Konsta M; Chrousos GP; Sfikakis PP
    J Rheumatol; 2012 Jan; 39(1):60-2. PubMed ID: 22133618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
    Kerekes G; Soltész P; Szucs G; Szamosi S; Dér H; Szabó Z; Csáthy L; Váncsa A; Szodoray P; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
    Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
    Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study.
    Bacchiega BC; Bacchiega AB; Usnayo MJ; Bedirian R; Singh G; Pinheiro GD
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28288972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6 as therapeutic target in athero-/arteriosclerosis--small steps towards a new treatment paradigm in cardiovascular disease?
    Henry RM
    Atherosclerosis; 2011 Dec; 219(2):390-1. PubMed ID: 21840523
    [No Abstract]   [Full Text] [Related]  

  • 7. [New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)].
    Nasonov EL
    Ter Arkh; 2010; 82(5):64-71. PubMed ID: 20597275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of tocilizumab for the treatment of patients with rheumatoid arthritis.
    Zhang X; Peck R
    Expert Rev Clin Pharmacol; 2011 Sep; 4(5):539-58. PubMed ID: 22114882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.
    Snir A; Kessel A; Haj T; Rosner I; Slobodin G; Toubi E
    Clin Exp Rheumatol; 2011; 29(4):697-700. PubMed ID: 21813064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of subcutaneous versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
    McLaughlin M; Östör A
    Expert Opin Drug Saf; 2015 Mar; 14(3):429-37. PubMed ID: 25553607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis.
    Mäki-Petäjä KM; Day L; Cheriyan J; Hall FC; Östör AJ; Shenker N; Wilkinson IB
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26896473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells.
    Muhammad K; Roll P; Seibold T; Kleinert S; Einsele H; Dörner T; Tony HP
    Ann Rheum Dis; 2011 Aug; 70(8):1507-10. PubMed ID: 21551509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting interleukin-6 in rheumatoid arthritis.
    Choy E
    Curr Rheumatol Rep; 2008 Oct; 10(5):413-7. PubMed ID: 18817647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis.
    Marder W; Khalatbari S; Myles JD; Hench R; Yalavarthi S; Lustig S; Brook R; Kaplan MJ
    Ann Rheum Dis; 2011 Sep; 70(9):1550-5. PubMed ID: 21727237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Treatments for Rheumatoid Arthritis on Endothelial Dysfunction Evaluated by Flow-Mediated Vasodilation in Patients with Rheumatoid Arthritis.
    Kotani K; Miyamoto M; Ando H
    Curr Vasc Pharmacol; 2017; 15(1):10-18. PubMed ID: 27739363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The importance of cytokine profile characteristics for evaluating the therapeutic effectiveness of monoclonal antibodies against IL-6 receptors in patients with rheumatoid arthritis].
    Avdeev AS; Novikov AA; Aleksandrova EN; Panasiuk EIu; Nasonov EL
    Klin Med (Mosk); 2014; 92(1):28-34. PubMed ID: 25265656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 inhibition and clinical efficacy in rheumatoid arthritis treatment--data from randomized clinical trials.
    Kavanaugh A
    Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S16-20. PubMed ID: 17708740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6: a new therapeutic target.
    Smolen JS; Maini RN
    Arthritis Res Ther; 2006; 8 Suppl 2(Suppl 2):S5. PubMed ID: 16899109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis.
    Marder W; Khalatbari S; Myles JD; Hench R; Lustig S; Yalavarthi S; Parameswaran A; Brook RD; Kaplan MJ
    J Am Heart Assoc; 2013 Nov; 2(6):e000441. PubMed ID: 24252844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tumor necrosis factor-α antagonists on arterial stiffness in rheumatoid arthritis: a literature review.
    Dulai R; Perry M; Twycross-Lewis R; Morrissey D; Atzeni F; Greenwald S
    Semin Arthritis Rheum; 2012 Aug; 42(1):1-8. PubMed ID: 22475245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.